Clinical Trials Logo

Filter by:
NCT ID: NCT03376347 Completed - Clinical trials for Intraoperative Hypotension

Intraoperative Implementation of the Hypotension Probability Indicator

HYPE
Start date: November 8, 2017
Phase: N/A
Study type: Interventional

Reducing intraoperative hypotension using FlotracIQ with HPI software.

NCT ID: NCT03376321 Terminated - Influenza A Clinical Trials

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Start date: January 3, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment.

NCT ID: NCT03375801 Completed - Breast Cancer Clinical Trials

Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment.

BRASA
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

This is a pre-and post intervention study on the effect and implementation of an personalized decision aid for woman with breast cancer who face a decision on their radiation treatment.

NCT ID: NCT03375697 Completed - Alzheimer Disease Clinical Trials

A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease

Start date: December 22, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of JNJ-63733657 following single ascending intravenous (IV) dose administration in healthy subjects (Part 1) and multiple ascending IV dose administrations in subjects with prodromal or mild Alzheimer's disease (AD) (Part 2).

NCT ID: NCT03375606 Terminated - Healthy Clinical Trials

Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults

Start date: January 10, 2018
Phase: Phase 1
Study type: Interventional

To assess the safety and tolerability of ascending doses of CSL730 after a single intravenous (IV) infusion in healthy Caucasian and Japanese subjects

NCT ID: NCT03374865 Recruiting - Clinical trials for Video-mediated Consultation

Is the Medium the Message?

Start date: June 1, 2017
Phase: N/A
Study type: Observational

Digital communication media like video‐interaction (cf. Skype) are increasingly being adopted in institutional environments like hospitals for physician‐patient interactions. We may expect that the use of a digital medium affects these interactions in various ways and on various levels. In video‐interaction, eye contact for example is impossible due to the position of the camera, which implies interactional behavior through gaze is impaired. This may influence who speaks when, if and how the participants avoid/ solve misunderstandings, etcetera. This project makes headway in our understanding of the impact of new communication media on the role of language‐in‐use as a rich semiotic system, specifically in institutional interaction. This type of contextualized research reveals which communicative aspects users consider important, how they manage their institutional relationship through them and how they go about solving communication problems. The project compares the interaction of physicians and patients in video‐mediated consultations to their traditional, face‐to‐face counterparts on both the verbal and the nonverbal (gaze) level. The affordances of video‐consultations with relevance to institutional goals and identities are analyzed through a comparison with the interaction in face‐to‐face consultations. The approach used is Conversation Analysis, which involves finding patterns on both the verbal and non‐verbal level (in sequences, turn design, preference, etc.) in order to answer the question what goals and tasks the participants achieve and what dilemma's or problems they aim to solve in their talk. This study will provide insights in the limitations and advantages of both channels of communication. Best practices will be generated and outcomes of the analyses will be used to develop reco

NCT ID: NCT03374826 Recruiting - Breast Cancer Clinical Trials

PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients

Start date: February 22, 2018
Phase: N/A
Study type: Interventional

Axillary lymph node status is an important prognostic factor for patients with breast cancer. After breast cancer diagnosis, current nodal staging consists of axillary ultrasound (US) combined with tissue sampling when deemed necessary. In case of positive axillary lymph nodes, patients will undergo axillary lymph node dissection (ALND). In case of no suspicious axillary lymph nodes (i.e. clinically node negative patients), patients will undergo sentinel lymph node biopsy (SLNB). This surgical nodal staging is accompanied by co-morbidity. In theory, if non-invasive imaging can evaluate the lymph node status accurately, a node negative patient would no longer have to undergo axillary surgery. Since MRI is suitable for soft tissue imaging and PET has the advantage of showing increased metabolic uptake in lymph node metastases, a combination of these techniques in hybrid PET/MRI would be highly desirable. If dedicated axillary hybrid PET/MRI is equally accurate to SLNB for the detection of negative axillary lymph nodes, work-up could be more efficient by bypassing SLNB. However, the accuracy of dedicated axillary hybrid PET/MRI needs to be compared with the pathological outcome of SLNB (gold standard) first.

NCT ID: NCT03374488 Completed - Clinical trials for UC (Urothelial Cancer)

Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma

Start date: December 22, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the efficacy and safety of pembrolizumab + epacadostat vs pembrolizumab + placebo as a treatment for recurrent or progressive metastatic urothelial carcinoma in patients who have failed a first-line platinum-containing chemotherapy regimen for advanced/metastatic disease.

NCT ID: NCT03374475 Completed - Clinical trials for Depressive Disorder, Major

A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder

Start date: January 5, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to explore if the magnitude of treatment effect (JNJ-42847922; placebo) on symptoms of depression (as measured by Hamilton rating scale for depression-17 [HDRS17], Sleep item-adjusted HDRS17, Anxiety/somatization factor score and the 6-item subscale from HDRS17 [HAM-D6]) differs across different levels of hyper-arousal status (characterized by Sleep parameters, ruminative response scale [RRS], Sleep and Worry visual analogue scale [VAS], quantitative electro-encephalography [qEEG], heart rate variability [HRV] and others).

NCT ID: NCT03373968 Enrolling by invitation - Clinical trials for Duchenne Muscular Dystrophy

Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

Start date: October 24, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one of the GIVINOSTAT studies.